BRCA1 and BRCA2 germline mutations driven signaling pathway alterations are sufficient to initiate breast tumorigenesis by the PIK3CA ^H1047R oncogene

Poornima Bhat‐Nakshatri, Harikrishna Nakshatri, Katie Batic et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023

Cited by 1